Oppenheimer Asset Management’s Array Biopharma Inc ARRY Stock Holding History

Oppenheimer Asset Management’s Portfolio ARRY Stock Details ARRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-3,217	Closed	-$149K	–	1676
2019 Q2	$149K	Sell	3,217 -25,553	-89%	-$717K	﹤0.01%	1123
2019 Q1	$701K	Buy	28,770 +2,394	+9%	+$49.8K	0.02%	700
2018 Q4	$376K	Buy	26,376 +10,248	+64%	+$155K	0.01%	838
2018 Q3	$245K	Buy	16,128 +4,746	+42%	+$72.7K	0.01%	1028
2018 Q2	$191K	Buy	+11,382	New	+$181K	﹤0.01%	1078

Other funds holding ARRY

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Oppenheimer Asset Management's ARRY Position: Q3 2019 in Review

Oppenheimer Asset Management sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 3,217 shares — an estimated $149K sold.

Oppenheimer Asset Management first reported a position in ARRY in Q2 2018 and held it in 5 quarters. The position peaked at $701K in Q1 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

Oppenheimer Asset Management reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
Oppenheimer Asset Management sold 3,217 Array Biopharma Inc shares in Q3 2019, an estimated $149K.
Oppenheimer Asset Management first reported a position in Array Biopharma Inc in Q2 2018 and held it in 5 quarters.
Oppenheimer Asset Management's Array Biopharma Inc position peaked at $701K in Q1 2019.
1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Oppenheimer Asset Management's 13F filing for Q3 2019, filed 31 Oct 2019.